← Eichor
Study identifier: NCT07019766 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

National Longitudinal Cohort of Hematological Diseases-Large Granular Lymphocytic Leukemia

Condition: T-LGL Leukemia · NK-LGL Leukemia  ·  Sponsor: Institute of Hematology & Blood Diseases Hospital, China

PhaseN/A
Planned participants9999
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

Hematological diseases are disorders of the blood and hematopoietic organs. The current hematological cohorts are mostly based on single-center or multi-center cases, or cohorts with limited sample size in China. There is a lack of comprehensive and large-scale prospective cohort studies in hematology. The objectives of this study are to investigate the incidence and risk factors of large granular lymphocytic leukemia (LGLL) and to analyze the treatment effectiveness, patient prognosis, and healthcare costs in China. 1. Analyze the demographic and clinical characteristics of patients with LGLL, including sex, age, disease severity, and other relevant factors. 2. Examine disease features of LGLL patients, such as biochemical and hematological indicators, LGL counts, clonality, bone marrow pathology, and cytogenetics 3. Assess treatment patterns and real-world effectiveness in LGLL patients. 4. Evaluate clinical outcomes, including hematologic response, relapse, and mortality 5. Investigate long-term prognosis, including post-discontinuation outcomes and health-related quality of life.

This description comes directly from the study's public registry record.

Talk to the study team

Lele Zhang, PhD  ·  ‭15811139278‬  ·  zhanglele@ihcams.ac.cn

Always discuss trial participation with your own doctor first.

Locations (1)

Red Blood Cell Diseases Center and Regenerative Medicine CenterTianjin, Tianjin Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07019766